Showing results (1-10 of 17,404) with videos related to
Sort By:
Pageof 1,741
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 14, 2002
Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variationJohn R Cashman, Jun ZhangAnnual Review of Pharmacology and Toxicology|January 13, 2006
Human flavin-containing monooxygenasesJohn R Cashman, Jun ZhangDrug Metabolism and Disposition: the Biological Fate of Chemicals|September 27, 2005
Quantitative analysis of FMO gene mRNA levels in human tissuesJun Zhang, John R CashmanMolecular Pharmacology|May 25, 2004
Alternative processing events in human FMO genesVirginie Lattard, Jun Zhang, John R CashmanExpert Opinion on Drug Metabolism & Toxicology|November 22, 2007
Flavin-containing monooxygenase 3 and human diseaseMeike S Motika, Jun Zhang, John R CashmanPharmacogenetics|August 2, 2003
Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuriaJun Zhang, Quyen Tran, Virginie Lattard, et al.The Journal of Pharmacology and Experimental Therapeutics|November 30, 2012
Immunodetection of serum albumin adducts as biomarkers for organophosphorus exposureSigeng Chen, Jun Zhang, Lucille Lumley, et al.Drug Metabolism Letters|April 10, 2009
Analysis of flavin-containing monooxygenase 3 genotype data in populations administered the anti-schizophrenia agent olanzapineJohn R Cashman, Jun Zhang, Matthew R Nelson, et al.Journal of Medicinal Chemistry|March 29, 2011
Amidine-oximes: reactivators for organophosphate exposureJarosław Kalisiak, Erik C Ralph, Jun Zhang, et al.Protein Expression and Purification|August 2, 2011
His-tag truncated butyrylcholinesterase as a useful construct for in vitro characterization of wild-type and variant butyrylcholinesterasesErik C Ralph, Longkuan Xiang, John R Cashman, et al.Pageof 1,741